Rapport Therapeutics, Inc. Contracts & Agreements
13 Contracts & Agreements
- Business Finance (4 contracts)
- Business Operations (1)
- Human Resources (3)
- Intellectual Property (2)
- Real Estate (2)
- Uncategorized (1)
- Employment Agreement, by and between the Company and Abraham N. Ceesay, M.B.A., effective as of June 10, 2024 (Filed With SEC on August 8, 2024)
- Employment Agreement, by and between the Company and Troy Ignelzi, effective as of June 10, 2024 (Filed With SEC on August 8, 2024)
- Employment Agreement, by and between the Company and Cheryl Gault, effective as of June 10, 2024 (Filed With SEC on August 8, 2024)
- Form of Stock Purchase Agreement, by and among the Company and the Purchasers (Filed With SEC on June 10, 2024)
- Specimen Common Stock Certificate (Filed With SEC on May 17, 2024)
- Amended and Restated Investors Rights Agreement, by and between the Registrant and certain of its stockholders, dated as of August 7, 2023 (Filed With SEC on May 17, 2024)
- 2022 Stock Option and Grant Plan, as amended, and form of award agreements thereunder (Filed With SEC on May 17, 2024)
- Option and License Agreement, by and between the Registrant and Janssen Pharmaceutica NV, dated August 9, 2022, as amended (Filed With SEC on May 17, 2024)
- Master Services Agreement, by and between the Registrant and NeuroPace Inc., dated November 28, 2023 (Filed With SEC on May 17, 2024)
- Statement of Work #1, by and between the Registrant and NeuroPace Inc., dated November 28, 2023, as amended March 1, 2024 (Filed With SEC on May 17, 2024)
- Sublease Agreement, by and between the Registrant and Whoop, Inc., dated June 15, 2023 (Filed With SEC on May 17, 2024)
- License Agreement, by and between the Registrant and ARE-SD Region No. 61, LLC, dated December 21, 2023 (Filed With SEC on May 17, 2024)
- Lease Agreement, by and between the Registrant and ARE-9880 Campus Point, LLC, dated February 12, 2024 (Filed With SEC on May 17, 2024)
